Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trial. [electronic resource]
Producer: 20190807Description: 1842-1850 p. digitalISSN:- 1398-9995
- Allergens -- administration & dosage
- Asthma -- complications
- Case-Control Studies
- Desensitization, Immunologic -- adverse effects
- Drug Administration Schedule
- Female
- Humans
- Male
- Peptides -- administration & dosage
- Poaceae -- adverse effects
- Pollen -- immunology
- Quality of Life
- Rhinitis, Allergic, Seasonal -- complications
- Seasons
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.